APOE and early-onset autosomal dominant Alzheimer disease: Combining the use of magnetic bead platforms and IrO2 NPs as labels of antibodies, they applied this catalytic method for the detection of ApoE, an Alzheimer’s disease biomarker at ng/mL levels (Figure 9B).